Sunitinib 12.5mg Wholesale USA | Licensed Pharmaceutical Exporter from India

Sutinat 12.5mg Capsule: Advanced Targeted Therapy for Cancer Treatment

Looking for a reliable Sutinat 12.5 mg capsule exporter from India? Ernest Oncology, a division of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of high-quality oncology medications. We specialize in providing life-saving treatments to the UK (London), USA, UAE (Abu Dhabi), Australia, and South Africa, ensuring seamless logistics and competitive B2B pricing.

Product Overview: What is Sutinat 12.5 mg?

Sutinat 12.5 mg contains Sunitinib, a potent multi-kinase inhibitor. It is a targeted therapy designed to disrupt the signaling pathways that allow cancer cells to grow, divide, and form new blood vessels (angiogenesis).

Key Therapeutic Indications:

Sutinat 12.5 mg is primarily prescribed for the management of:

• Metastatic Renal Cell Carcinoma (MRCC): Advanced kidney cancer that has spread to other parts of the body.

• Gastrointestinal Stromal Tumor (GIST): Specifically for patients who have not responded to imatinib or cannot tolerate it.

• Pancreatic Neuroendocrine Tumors (pNET): Well-differentiated, progressive tumors of the hormone-producing cells in the pancreas.

How Sutinat Works (Mechanism of Action): 

Sutinat belongs to the class of Tyrosine Kinase Inhibitors (TKIs). It targets several specific receptors on the surface of cancer cells, including:

1. VEGFR (Vascular Endothelial Growth Factor Receptor): Stops the formation of blood vessels that feed the tumor.

2. PDGFR (Platelet-Derived Growth Factor Receptor): Inhibits the growth and survival of cancer cells.

3. c-KIT: A critical target for treating GIST.

By blocking these proteins, Sutinat effectively starves the tumor of nutrients and inhibits its ability to replicate.

Dosage and Administration:

• Standard Cycle: For RCC and GIST, the typical regimen is 50 mg (multiple capsules) daily for 4 weeks, followed by a 2-week rest period.

• pNET Protocol: For pancreatic tumors, a continuous daily dose (often 37.5 mg) is commonly used.

• Method: Should be swallowed whole with water, with or without food. Do not consume grapefruit or grapefruit juice during treatment, as it can interfere with the drug's effectiveness.

Common Side Effects:

While highly effective, patients may experience:

• Fatigue and weakness

• Nausea, vomiting, or diarrhea

• Hand-Foot Syndrome: Redness, swelling, or pain on palms and soles.

• Skin or hair discoloration (lightening).

• High blood pressure (hypertension).

Why Choose Ernest Oncology for Bulk Supply?

• Certified Quality: Sourced from world-class manufacturers like Natco Pharma Ltd.

• Global Reach: Rapid shipping to the USA, UK, UAE, Australia, and South Africa.

• Bulk Availability: Consistent stock of Sunitinib 12.5 mg, 25 mg, and 50 mg strengths.

• B2B Expertise: Specialized in international pharmaceutical laws and customs documentation.